These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36777091)

  • 1. Health equity considerations in pragmatic trials in Alzheimer's and dementia disease: Results from a methodological review.
    Nicholls SG; Al-Jaishi AA; Niznick H; Carroll K; Madani MT; Peak KD; Madani L; Nevins P; Adisso L; Li F; Weijer C; Mitchell SL; Welch V; Quiñones AR; Taljaard M
    Alzheimers Dement (Amst); 2023; 15(1):e12392. PubMed ID: 36777091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting of health equity considerations in cluster and individually randomized trials.
    Petkovic J; Jull J; Yoganathan M; Dewidar O; Baird S; Grimshaw JM; Johansson KA; Kristjansson E; McGowan J; Moher D; Petticrew M; Robberstad B; Shea B; Tugwell P; Volmink J; Wells GA; Whitehead M; Cuervo LG; White H; Taljaard M; Welch V
    Trials; 2020 Apr; 21(1):308. PubMed ID: 32245522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How effects on health equity are assessed in systematic reviews of interventions.
    Welch V; Dewidar O; Tanjong Ghogomu E; Abdisalam S; Al Ameer A; Barbeau VI; Brand K; Kebedom K; Benkhalti M; Kristjansson E; Madani MT; Antequera Martín AM; Mathew CM; McGowan J; McLeod W; Park HA; Petkovic J; Riddle A; Tugwell P; Petticrew M; Trawin J; Wells GA
    Cochrane Database Syst Rev; 2022 Jan; 1(1):MR000028. PubMed ID: 35040487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reporting of health equity considerations in vaccine trials for COVID-19: a methodological review.
    Kou R; Sadafi SL; Principato R; Anderson LN; Brignardello-Petersen R; Mbuagbaw L
    J Clin Epidemiol; 2024 May; 169():111315. PubMed ID: 38447854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions to improve access to cataract surgical services and their impact on equity in low- and middle-income countries.
    Ramke J; Petkovic J; Welch V; Blignault I; Gilbert C; Blanchet K; Christensen R; Zwi AB; Tugwell P
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011307. PubMed ID: 29119547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Considerations and guidance in designing equity-relevant clinical trials.
    Mbuagbaw L; Aves T; Shea B; Jull J; Welch V; Taljaard M; Yoganathan M; Greer-Smith R; Wells G; Tugwell P
    Int J Equity Health; 2017 Jun; 16(1):93. PubMed ID: 28583125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do quality improvement initiatives for diabetes care address social inequities? Secondary analysis of a systematic review.
    Lu JB; Danko KJ; Elfassy MD; Welch V; Grimshaw JM; Ivers NM
    BMJ Open; 2018 Feb; 8(2):e018826. PubMed ID: 29444781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring equity in primary-care-based physical activity interventions using PROGRESS-Plus: a systematic review and evidence synthesis.
    Attwood S; van Sluijs E; Sutton S
    Int J Behav Nutr Phys Act; 2016 May; 13():60. PubMed ID: 27206793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methodological challenges in pragmatic trials in Alzheimer's disease and related dementias: Opportunities for improvement.
    Taljaard M; Li F; Qin B; Cui C; Zhang L; Nicholls SG; Carroll K; Mitchell SL
    Clin Trials; 2022 Feb; 19(1):86-96. PubMed ID: 34841910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is equity considered in systematic reviews of interventions for mitigating social isolation and loneliness in older adults?
    Madani MT; Madani L; Ghogomu ET; Dahrouge S; Hébert PC; Juando-Prats C; Mulligan K; Welch V
    BMC Public Health; 2022 Dec; 22(1):2241. PubMed ID: 36456997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of health equity consideration in masking/PPE policies to contain COVID-19 using PROGRESS-plus framework: a systematic review.
    Chhibber A; Kharat A; Kneale D; Welch V; Bangpan M; Chaiyakunapruk N
    BMC Public Health; 2021 Sep; 21(1):1682. PubMed ID: 34525995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving Health Equity in Embedded Pragmatic Trials for People Living with Dementia and Their Family Caregivers.
    Quiñones AR; Mitchell SL; Jackson JD; Aranda MP; Dilworth-Anderson P; McCarthy EP; Hinton L
    J Am Geriatr Soc; 2020 Jul; 68 Suppl 2(Suppl 2):S8-S13. PubMed ID: 32589281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How Is Health Equity Assessed in Cochrane Musculoskeletal Reviews?
    Janusz N; Dewidar O; Dowling S; Wang H; Buchbinder R; Conde M; Ghogomu ET; Maxwell L; Tugwell P; Howe T; Welch V
    J Rheumatol; 2022 Dec; 49(12):1379-1384. PubMed ID: 35970529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Best Practice Recommendations for Integrating Health Equity into Pragmatic Clinical Trials for Dementia Care.
    Mitchell S; McCarthy E; Hinton L; Nkimbeng M; Peak KD; Quiñones AR
    Ethn Dis; 2023 Apr; 33(2-3):84-90. PubMed ID: 38845735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social determinants of health in prognostic machine learning models for orthopaedic outcomes: A systematic review.
    Lans A; Kanbier LN; Bernstein DN; Groot OQ; Ogink PT; Tobert DG; Verlaan JJ; Schwab JH
    J Eval Clin Pract; 2023 Mar; 29(2):292-299. PubMed ID: 36099267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equity Considerations in COVID-19 Vaccination Studies of Individuals With Autoimmune Inflammatory Rheumatic Diseases.
    Wang H; Dewidar O; Whittle SL; Ghogomu E; Hazlewood G; Leder K; Mbuagbaw L; Pardo Pardo J; Robinson PC; Buchbinder R; Welch V
    Arthritis Care Res (Hoboken); 2023 May; 75(5):967-974. PubMed ID: 36194078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using PROGRESS-plus to identify current approaches to the collection and reporting of equity-relevant data: a scoping review.
    Karran EL; Cashin AG; Barker T; Boyd MA; Chiarotto A; Dewidar O; Mohabir V; Petkovic J; Sharma S; Tejani S; Tugwell P; Moseley GL
    J Clin Epidemiol; 2023 Nov; 163():70-78. PubMed ID: 37802205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparing for pragmatic trials in dementia care: Health equity considerations for nonpharmacological interventions.
    Aranda MP; Baier R; Hinton L; Peak KD; Jackson JD; Dilworth-Anderson P; Gitlin LN; Jutkowitz E; Quiñones AR
    J Am Geriatr Soc; 2023 Dec; 71(12):3874-3885. PubMed ID: 37656062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.